1Nichols WC, Dwulet FE, Liepnieks J, et al. Variant apolipoprotein AI as a major constituent of a human hereditary amyloid [J]. Biochem Biophys Res Comm, 1988,156:762 - 768.
2Higuchi K, Naiki H, Kitagawa K, et al. A polipoprotein A2 gene and development of amyloidosis and senesence in a congenic starain of mice carrying amyloidogeneic Apo A2 [J]. Lab Invest, 1995,72:75 - 82.
3Sun X,Ando Y, Haraoka K,et al, Role of VLDL/chylomicron in amyloid formation in familial amyloidotic polyneuropathy[J]. Biochem Biophys Res Comm,2003,311:344 - 350.
4Sun X, Ueda M, Yamashita T, et al. Lipid droplets are present in amyloid deposits in familial amyloidotic polyneuropathy and dialysis related amyloidosis[J]. Amyloid, 2006,13:20 - 23.
5Ando Y,Araki S, Ando M. Transthyretin and familial amyloidotic polyneuropathy[J]. Intern Med, 1993,32:920 - 922.
6Drugge U, Andersson R, Chizari F, et al. Familial amyloidotic polyneuropathy in Sweden a pedigree analysis[J]. J Med Genet, 1993,30:388 - 392 .
7Ando Y,Nyhlin N,Suhr O,et al. Oxidative stress is found in amyloid deposits in systemic amyloidosis[J]. Biochem Biophys Res Commun, 1997,232:497 - 502.
8Sato T, Susuki S, Suico MA, et al. Endoplasmic reticulum quality control regulates the fate of transthyretin variants in the cell [J]. Embo J,2007,26 :2501 - 2512.
3Marchi N, Mazzone P, Fazio V, et al. ProApoli- poprotein A1 : a serum marker of brain metastases in lung cancer patients [ J ]. Cancer, 2008, 112 ( 6 ) : 1313-1324.
4Qiu JG, Fan J, Liu YK, et al. Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma [ J ]. J Cancer Res Clin Oncol, 2008, 134(3) : 299-305.
5Bernstein LH. The systemic inflammatory response syndrome C-reactive protein and transthyretin conundrum [ J ]. Clin Chem Lab Med, 2007, 45 (11) : 1566-1567.
6Doherty NS, Littman BH, Reilly K. Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis [ J ]. Electrophoresis, 1998, 19(2): 355-363.
7Perdivara I, Petrovich R, Allinquant B, et al. Elucidation of O-glycosylation structures of the beta- amyloid precursor protein by liquid chromatographymass spectrometry using electron transfer dissociation and collision induced dissociation [ J ]. J Proteome Res, 2009, 8 (2) : 631-642.
8Sun X, Ando Y, Haraoka K, et al. Role of VLDL/ chylomicron in amyloid formation in familial amyloidotic polyneuropathy [ J ]. Biochem Biophys Res Commun, 2003, 311 (2) : 344-350.
9Ueda M, Misumi Y, Mizuguchi M, et al. SELDI- TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy[ J]. Clin Chem, 2009, 55(6) : 1223-1227.
10Zhang Q, Kelly JW. Cys- 10 mixed disulfide modi-fications exacerbate transthyretin familial variant amy- loidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice? [J]. Biochemistry, 2005,44(25) :9079 - 9085.
